InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: None

Thursday, 12/10/2020 6:18:08 PM

Thursday, December 10, 2020 6:18:08 PM

Post# of 232528
"371 people have enrolled in CD-12, so we're going directly to full-trial results."

Yep, a PR with that statement would have sufficed today. And it would (certainly should!) have been received positively. But I'm happy to hear the comments that add texture to the recruitment dynamics.

Defining the Longhaulers MOA - an essential step to getting a Phase 2 approved ahead of the pack - a huge step and a small step at the same time. Discussion ideal for a science-driven investor base. Few people would review that if written out.

Working the international opportunities - the texture of this conveyed the squishy, but non-zero, nature of these possibilities. No way a PR could have communicated this.

All the rest adds to soup to me - every piece is important to someone - that's the nature of an update. All heading forward, all sounding tasty. No way it fits in a PR.

Yeah, exactly what I expect from a CytoDyn CC, and I'm happy about it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News